Top 50 Affinity Asset Advisors, LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 6.34% | 1.28M | $108.2M | +4.05%(+50.00K) | $42.21(+214.87%) | 2026-03-31 | |
| XENE | XENON PHARMACEUTICALS INC | 5.71% | 1.68M | $97.4M | +34.00%(+425.00K) | $42.04(+44.99%) | 2026-03-31 | |
| ERAS | ERASCA INC | 5.08% | 5.35M | $86.6M | +37.18%(+1.45M) | $4.15(+345.12%) | 2026-03-31 | |
| INSM | INSMED INC | 4.6% | 480.0K | $78.5M | +6.67%(+30.00K) | $87.15(+28.05%) | 2026-03-31 | |
| ROIV | ROIVANT SCIENCES LTD | 4.55% | 2.80M | $77.6M | +64.71%(+1.10M) | $19.05(+84.46%) | 2026-03-31 | |
| SYRE | SPYRE THERAPEUTICS INC | 3.78% | 1.28M | $64.5M | -10.71%(-153.46K) | $17.62(+391.55%) | 2026-03-31 | |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 3.26% | 1.40M | $55.6M | +133.12%(+799.45K) | $23.50(+72.37%) | 2026-03-31 | |
| PRAX | PRAXIS PRECISION MEDICINES I | 3.21% | 170.0K | $54.8M | -8.11%(-15.00K) | $173.87(+83.19%) | 2026-03-31 | |
| ANAB | ANAPTYSBIO INC | 3.06% | 940.0K | $52.1M | +111.38%(+495.31K) | $30.73(+106.38%) | 2026-03-31 | |
| ALKS | ALKERMES PLC | 2.8% | 1.35M | $47.7M | +35.00%(+350.00K) | $28.06(+94.49%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +29.52% | +117.28% |
| Top 20 Holdings Unweighted | +38.62% | +166.35% |
Sign up free to track Affinity Asset Advisors, LLC, compare funds side by side, and get alerts the moment positions change.